Evaluation of QDOT MICRO catheter for pulmonary vein isolation (PVI) in subjects with Paroxysmal Atrial Fibrillation (PAF)
Enrolling By Invitation
18 years - 99 years
All
27 participants needed
1 Location
Brief description of study
The purpose of this study is to demonstrate the safety and 12-Month effectiveness of the QDOT MICRO catheter when used with the nMARQ RF generator in the treatment of drug refractory symptomatic paroxysmal atrial fibrillation (PAF) during standard electrophysiology mapping and RF ablation procedures.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: PVI
-
Age: 18 years - 99 years
-
Gender: All
Updated on
19 Feb 2024.
Study ID: 832799
If you need help finding a study or have any questions, please contact us at psom-ocr@pobox.upenn.edu
